Key facts
- This page summarizes Daniel J. Starks's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 May 2022, 18:23.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Footnote F2
Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.